Enterococcus casseliflavus bacteremia. Case report and literature review

Journal of Infection

Volumn 48, Issue 2, 2004, Pages 206-208

  Pappas, G ^a   Liberopoulos, E ^a   Tsianos, E ^a   Elisaf, M ^a  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

Enterococcus casseliflavus; Motile Enterococci; Vancomycin resistance

Indexed keywords

AMIKACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL VIRULENCE; BILE DUCT CARCINOMA; BLOOD CULTURE; CASE REPORT; ENTEROCOCCUS CASSELIFLAVUS; ESCHERICHIA COLI; FEMALE; HUMAN; LIVER BIOPSY; MEDICAL LITERATURE; MINIMUM INHIBITORY CONCENTRATION; MORGANELLA MORGANII; RETROSPECTIVE STUDY;

EID: 1642546428     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2003.08.001     Document Type: Article

References (19)

1. Murray BE. The life and times of the Enterococcus. Clin Microbiol Rev 1990;3:46-56.
2. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991; 91:72S-75S.
3. Rice LB. Emergence of vancomycin-resistant Enterococci. Emerg Infect Dis 2001;7:183-187.
4. Edmond MB, Ober JF, Dawson JD, Weinbaum DL, Wenzel RP. Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin Infect Dis 1996;23: 1234-1239.
5. Moellering Jr. RC. Vancomycin-resistant Enterococci. Clin Infect Dis 1998;26:1196-1199.
6. Ramotar K, Woods W, Larocque L, Toye B. Comparison of phenotypic methods to identify Enterococci intrinsically resistant to vancomycin (VanC VRE). Diagn Microbiol Infect Dis 2000;36:119-124.
7. Facklam RR, Collins MD. Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol 1989;27:731-734.
8. Cartwright CP, Stock F, Fahle GA, Gill VJ. Comparison of pigment production and motility tests with PCR for reliable identification of intrinsically vancomycin-resistant Enterococci. J Clin Microbiol 1995;33:1931-1933.
9. Vincent S, Knight RG, Grfeen M, Sahm DF, Shlaes DM. Vancomycin susceptibility and identification of motile Enterococci. J Clin Microbiol 1991;29:2335-2337.
10. Coque TM, Tomayko JF, Ricke SC, Okhuysen PC, Murray BE. Vancomycin-resistant Enterococci from nosocomial, community, and animal sources in the United States. Antimicrob Agents Chemother 1996;40:2605-2609.
11. Robredo B, Singh KV, Baquero F, Murray BE, Torres C. Vancomycin-resistant Enterococci isolated from animals and food. Int J Food Microbiol 2000;54:197-204.
12. Arthur M, Reynolds PE, Depardieu F, Evers S, Dutka-Malen S, Quintillani Jr. R, Courvalin P. Mechanisms of glycopeptide resistance in Enterococci. J Infect 1996;32:11-16.
13. Toye B, Shymanski J, Bobrowska M, Woods W, Ramotar K. Clinical and epidemiological significance of Enterococci intrinsically resistant to vancomycin (possessing the VanC genotype). J Clin Microbiol 1997;35:3166-3170.
14. Ratanasuwan W, Iwen PC, Hinrichs SH, Rupp ME. Bacteremia due to motile Enterococcus species: clinical features and outcomes. Clin Infect Dis 1999;28:1175-1177.
15. Patterson JE, Sweeney AH, Simms M, Carley N, Mangi R. Sabetta J, Lyons RW. An analysis of 110 serious enterococcal infections. Epidemiology, antibiotic susceptibility, and outcome. Medicine 1995;74:191-200.
16. Van Horn KG, Rodney KM. Colonization and microbiology of the motile enterococci in a patient population. Diagn Microbiol Infect Dis 1998;31:525-530.
17. Reid KC, Cockerill III FR, Patel R. Clinical and epidemiological features of Enterococcus cosseliflavus/flavescens and Enterococcus gallinarum bacteremia: a report of 20 cases. Clin Infect Dis 2001;32:1540-1546.
18. Mc Dermott C, Mylotte JM. Morganella morganii: epidemiology of bacteremic disease. Infect Control 1984;5:131-137.
19. Edmond MB, Ober JF, Weinbaum DL, Pfaller MA, Hwang T, Sanford MD, Wenzel RP. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995;20:1126-1133.